These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3157510)

  • 81. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay.
    Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A
    Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of Graves' IgG on gene transcription in human thyroid cell cultures. Thyroglobulin gene activation.
    Kung AW; Collison K; Banga JP; McGregor AM
    FEBS Lett; 1988 May; 232(1):12-6. PubMed ID: 2835260
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Studies of possible antiidiotypic control mechanisms in Graves' disease.
    Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
    J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
    Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
    J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY; Walfish PG
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus.
    Topliss D; How J; Lewis M; Row V; Volpé R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):700-5. PubMed ID: 6224805
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
    Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Homing of 51Cr-labeled human peripheral lymphocytes to Graves' thyroid tissue xenografted into SCID mice.
    Resetkova E; Nishikawa M; Mukuta T; Arreaza G; Fornasier VL; Volpé R
    Thyroid; 1995 Aug; 5(4):293-8. PubMed ID: 7488871
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Accumulation of identical T cell clones in the right and left lobes of the thyroid gland in patients with Graves' disease: analysis of T cell clonotype in vivo.
    Sekine T; Kato R; Kato T; Masuko-Hongo K; Kameko F; Maruyama M; Nishioka K; Yamamoto K
    Endocr J; 2000 Apr; 47(2):127-36. PubMed ID: 10943736
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Studies of immunoglobulin synthesis in cultures of peripheral T and B lymphocytes: reduced T-suppressor cell activity in Graves' disease.
    Pacini F; DeGroot LJ
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):219-32. PubMed ID: 6222851
    [No Abstract]   [Full Text] [Related]  

  • 91. Adenylate cyclase stimulation and [3H]thymidine incorporation in human thyroid tissues and thyrocyte cultures: the effect of IgG preparation from patients with different thyroid disorders.
    Goretzki PE; West M; Koob R; Koller C; Joseph K; Röher HD
    Acta Endocrinol Suppl (Copenh); 1987; 281():281-7. PubMed ID: 3475910
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The behaviour of suppressor-inducer T cells following treatment for Graves' disease.
    Wilson R; Pearson C; McKillop JH; Burnett AK; Thomson JA
    Autoimmunity; 1990; 6(1-2):93-7. PubMed ID: 2151791
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Thyroid cell survival in coculture with autologous peripheral or intrathyroidal lymphocytes.
    Massart C; Gibassier J; Le Gall F; Raoul ML; Beurtin F; Genetet B; Lucas C
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):379-87. PubMed ID: 7750192
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Complement component C9 in Graves' disease.
    Oleesky DA; Ratanachaiyavong S; Ludgate M; Morgan BP; Campbell AK; McGregor AM
    Clin Endocrinol (Oxf); 1986 Dec; 25(6):623-32. PubMed ID: 3308182
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The operation of immunological networks in Graves' disease.
    Farid NR; Newton RM; Noel EP; Barnard JM; Marshall WH
    Tissue Antigens; 1978 Sep; 12(3):205-11. PubMed ID: 83018
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Studies on suppressor T lymphocyte function in Graves' disease by 3H-thymidine interpolation.
    Fang WY; Ye WX
    J Tongji Med Univ; 1987; 7(1):40-3. PubMed ID: 2439704
    [No Abstract]   [Full Text] [Related]  

  • 97. Effect of monensin on DNA synthesis in cultured human thyroid cells.
    Okugawa T; Itoh M
    Endocr J; 1993 Feb; 40(1):53-62. PubMed ID: 7951497
    [TBL] [Abstract][Full Text] [Related]  

  • 98. T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves' disease.
    How J; Topliss DJ; Strakosch C; Lewis M; Row VV; Volpé R
    Clin Endocrinol (Oxf); 1983 Jan; 18(1):61-71. PubMed ID: 6221835
    [No Abstract]   [Full Text] [Related]  

  • 99. Inactivation of human thyroid stimulator by human thyroid extract.
    Shishiba Y; Takaishi M; Shimizu T
    Endocrinol Jpn; 1979 Apr; 26(2):285-9. PubMed ID: 225166
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Graves' disease thyroid tissue transplants in scid mice: persistent selectivity in hTcR Va gene family use.
    De Riu S; Martin A; Valentine M; Concepcion ES; Shultz LD; Davies TF
    Autoimmunity; 1994; 19(4):271-7. PubMed ID: 7578854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.